VI 0162
Latest Information Update: 10 Dec 2021
At a glance
- Originator VIVUS
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Premature ejaculation
Most Recent Events
- 18 Sep 2006 Discontinued - Phase-I for Premature ejaculation in USA (PO)
- 30 Jun 2003 VIVUS has completed a phase I at-home trial in premature ejaculation in the USA
- 25 Nov 2002 Phase-I clinical trials in Premature ejaculation in USA (PO)